Clinical trial · Interventional
Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers
Visual Communication: Can a Digital Tool Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers?
NCT06927050CI-TRIAL-00104039recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a study in patients with newly diagnosed cancer to prospectively evaluate the feasibility of integration of a visual communication tool for patients/caregivers/providers by determining whether such a tool can increase overall satisfaction with the patient experience.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Visual Communication Tool | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patients (and caregivers) recently diagnosed with cancer
- description
- Enrolled patients will receive a tool during the patient consultation encounter to explain their disease location and stage, role of radiation, logistics of radiation treatment delivery and sequencing of treatment. Following the encounter, a survey will be provided. If patients are accompanied by a caregiver(s), they will also receive a survey.
- interventionNames
- Behavioral: Visual Communication Tool
Primary outcomes (1)
- measure
- Percentage of "Satisfied" Patients
- timeFrame
- Day 0
- description
- Patients will take a 9-item survey assessing satisfaction with the intervention. Each item is rated as "Yes" or "No." The total score is the sum of "Yes" responses; patients with 6 or more "Yes" answers out of 9 questions are defined as "Satisfied" patients.
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: Patients: * Patients seen in consultation from 12/1/2024-6/1/2025 * Patients aged 18 years to 100 years old * Patients with a malignancy of breast or head and neck * English speaking patients * Patients being treated with definitive intent * Patients treated at NYU Langone Health for their malignancy * Willing and able to provide consent Caregivers: * Any adult caregiver(s) (aged 18 years to 100 years old) to a patient who fulfills the inclusion and exclusion criteria above. * Willing and able to provide consent Providers: * Doctors and nurse practitioners in medical oncology and radiation oncology, and in the ear nose throat (ENT) department. * Willing and able to provide consent * aged 18 years to 100 years old Exclusion Criteria: Patients: * Patients with any other site of disease other than listed above * Non-English-speaking patients, as the tool is currently available in English only. Translation into additional languages such as Spanish and Russian is currently in process. * Patient unable to complete the survey portion of the study independently Caregivers: • Unable to complete the survey portion of the study independently
References
Publications (0)
Data not yet available
No reference posted for this study.